Literature DB >> 9777278

Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates.

M Zimmerman1, J I Mattia.   

Abstract

The prevalence of Body Dysmorphic Disorder (BDD), based on structured and unstructured clinical interviews, was compared in two samples of psychiatric outpatients drawn from the same practice setting. In the first sample, 500 patients were diagnosed according to a routine, unstructured clinical interview. In the second sample, 500 subjects were diagnosed according to information obtained by the Structured Clinical Interview for DSM-IV (SCID). No patient was diagnosed with BDD in the clinical sample, whereas 16 (3.2%) patients were diagnosed with BDD in the SCID sample. Compared with patients without BDD, patients with BDD received significantly more current axis I diagnoses, and were more likely to be diagnosed with current obsessive-compulsive disorder (OCD) and social phobia. Both groups were diagnosed with major depression at similar rates. Patients with BDD, versus those without, tended to be sicker and more functionally impaired. It appears that BDD is an infrequent disorder in an outpatient setting, which is rarely recognized when clinicians conduct their routine diagnostic interview. Although it was not usually a patient's principal reason for seeking treatment, the majority of patients with BDD in this sample wanted their treatment to address these symptoms.

Entities:  

Mesh:

Year:  1998        PMID: 9777278     DOI: 10.1016/s0010-440x(98)90034-7

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  26 in total

1.  An Empirical Model of Body Image Disturbance Using Behavioral Principles found in Functional Analytic Psychotherapy and Acceptance and Commitment Therapy.

Authors:  Glenn M Callaghan; Julissa A Duenas; Sarah E Nadeau; Sabrina M Darrow; Jessica Van der Merwe; Jennifer Misko
Journal:  Int J Behav Consult Ther       Date:  2012-04-01

2.  Substance use disorders in individuals with body dysmorphic disorder.

Authors:  Jon E Grant; William Menard; Maria E Pagano; Christina Fay; Katharine A Phillips
Journal:  J Clin Psychiatry       Date:  2005-03       Impact factor: 4.384

3.  Body dysmorphic disorder: recognizing and treating imagined ugliness.

Authors:  Katharine A Phillips
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

4.  Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard
Journal:  Ann Clin Psychiatry       Date:  2006 Oct-Dec       Impact factor: 1.567

5.  Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder.

Authors:  Katharine A Phillips; Elizabeth R Didie; William Menard
Journal:  J Affect Disord       Date:  2006-08-07       Impact factor: 4.839

Review 6.  Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.

Authors:  Katharine A Phillips; Jamison Rogers
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

7.  Body dysmorphic disorder and social phobia: cross-sectional and prospective data.

Authors:  Meredith E Coles; Katharine A Phillips; William Menard; Maria E Pagano; Christina Fay; Risa B Weisberg; Robert L Stout
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

Review 8.  Body dysmorphic disorder and depression: theoretical considerations and treatment strategies.

Authors:  K A Phillips
Journal:  Psychiatr Q       Date:  1999

Review 9.  Relationship between social anxiety disorder and body dysmorphic disorder.

Authors:  Angela Fang; Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2010-08-14

10.  Appearance evaluation of others' faces and bodies in anorexia nervosa and body dysmorphic disorder.

Authors:  Teena D Moody; Vivian W Shen; Nathan L Hutcheson; Jennifer R Henretty; Courtney L Sheen; Michael Strober; Jamie D Feusner
Journal:  Int J Eat Disord       Date:  2016-08-27       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.